Literature DB >> 7219571

Yohimbine diastereoisomers: cardiovascular effects after central and peripheral application in the rat.

R W Rockhold, F Gross.   

Abstract

The cardiovascular effects of four yohimbine diastereoisomers, yohimbine, rauwolscine, corynanthine, and 3-epi-alpha-yohimbine, were compared in urethane-anaesthetized and conscious, normotensive Sprague-Dawley rats. Intravenous cumulative infusions (10--500 microgram) of the drugs to anaesthetized rats decreased blood pressure and blunted the pressor response to intravenous adrenaline injections. Corynanthine was the most potent isomer in this regard, followed by yohimbine, rauwolscine, and 3-epi-alpha-yohimbine. Depressor responses following intravenous bolus doses (40 microgram) showed a similar ranking. Intraventricular injections of yohimbine to anaesthetized rats decreased blood pressure dose-dependently, as did injections of corynanthine and rauwolscine. Responses indicated the ranking to be yohimbine greater or equal to rauwolscine greater than corynanthine for this effect at the 40 microgram dose. Heart rate was also decreased by these isomers, but not in a dose-dependent fashion. In conscious rats, the intraventricular injection of these isomers (20 microgram) increased blood pressure and heart rate. No differences were noted in terms of blood pressure responses; but, in causing tachycardia, the ranking was rauwolscine greater than yohimbine greater than corynanthine. These data suggest that after intraventricular application in anaesthetized rats, the effects of these alpha-adrenoceptor blockers are related to their individual affinity for the alpha 2 adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7219571     DOI: 10.1007/bf00499839

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Observations on the initial hypertensive response to yohimbine.

Authors:  C G INGRAM; E F DOMINO
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  High selectivity of rauwolscine for presynaptic alpha-adrenoceptors.

Authors:  T Tanaka; R Weitzell; K Starke
Journal:  Eur J Pharmacol       Date:  1978-11-15       Impact factor: 4.432

4.  An evaluation of adrenergic blocking agents.

Authors:  G CHEN; V L NASH; D RUSSELL
Journal:  Arch Int Pharmacodyn Ther       Date:  1950-12

5.  Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.

Authors:  K Starke; E Borowski; T Endo
Journal:  Eur J Pharmacol       Date:  1975-12       Impact factor: 4.432

6.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

7.  Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat.

Authors:  P B Timmermans; H Y Kwa; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

8.  A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anaesthetized rat.

Authors:  K R Borkowski; L Finch
Journal:  J Pharm Pharmacol       Date:  1979-01       Impact factor: 3.765

9.  Pharmacological and biochemical properties of isomeric yohimbine alkaloids.

Authors:  G A Lambert; W J Lang; E Friedman; E Meller; S Gershon
Journal:  Eur J Pharmacol       Date:  1978-05-01       Impact factor: 4.432

10.  Central and peripheral actions of two yohimbine-isomers (serpine and rauwolscine).

Authors:  A CHATTERJEE; S R DAS GUPTA; G WERNER
Journal:  Indian J Med Res       Date:  1954-10       Impact factor: 2.375

View more
  4 in total

1.  Is the sympathoexcitatory effect of yohimbine determined by brain yohimbine concentration?

Authors:  Y J Kuo; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

2.  The place of alpha-adrenoceptor and beta-adrenoceptor blockade in the treatment of hypertension.

Authors:  F Gross
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

3.  Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.

Authors:  J C Doxey; A C Lane; A G Roach; N K Virdee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

4.  The pharmacokinetic properties of yohimbine in the conscious rat.

Authors:  J W Hubbard; S L Pfister; A M Biediger; T C Herzig; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.